ResearcherNortheastern UniversityActive in the last 2 years
Mansoor M. Amiji
Matched on ORCID iD 0000-0001-6170-881X; OpenAlex author ID A5064469636; NIH RePORTER profile ID 1966327. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 1, last author 7)
- Trials
- 0
- Grants
- 3
- Labs led
- 1
- Collaborators
- 11
2012: 1 paper · 2013: none · 2014: 1 paper, 1 grant · 2015: none · 2016: 2 papers · 2017: none · 2018: 1 paper, 1 grant · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 grant
Papers 8
- Strategic modulation of the gastrointestinal microbiome to enhance pancreatic cancer immunotherapy. Last author DOI 10.1016/j.drudis.2025.104528↗
- Hyaluronic acid nanoparticle-encapsulated microRNA-125b repolarizes tumor-associated macrophages in pancreatic cancer. Last author DOI 10.2217/nnm-2021-0080↗
- DHA-SBT-1214 Taxoid Nanoemulsion and Anti-PD-L1 Antibody Combination Therapy Enhances Antitumor Efficacy in a Syngeneic Pancreatic Adenocarcinoma Model. Last author DOI 10.1158/1535-7163.mct-18-1046↗
- In vitro model of inflammatory, hypoxia, and cancer stem cell signaling in pancreatic cancer using heterocellular 3-dimensional spheroids Last author DOI 10.1101/454397↗
- EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model. Last author DOI 10.1016/j.nano.2015.11.010↗
- Pancreatic Cancer Cell Exosome-Mediated Macrophage Reprogramming and the Role of MicroRNAs 155 and 125b2 Transfection using Nanoparticle Delivery Systems. Last author DOI 10.1038/srep30110↗
- Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer. Last author DOI 10.1186/1471-2407-14-75↗
- Therapeutic gene delivery and transfection in human pancreatic cancer cells using epidermal growth factor receptor-targeted gelatin nanoparticles. First author DOI 10.3791/3612↗
Grants 3
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Gerardo Guillermo Mackenzie · 3 shared papers, 2 shared grants, 2018–2026 · strength 1.86
- Grant TGX-1214 - Combination Strategy for the Treatment of Advanced Pancreatic Cancer R01CA269233↗
- Grant Reprogramming Tumor-Associated Macrophages in PDAC with MicroRNA Nano-Vectors R21CA213114↗
- Paper Strategic modulation of the gastrointestinal microbiome to enhance pancreatic cancer immunotherapy. DOI 10.1016/j.drudis.2025.104528↗
- James E Egan · 1 shared grant, 2026 · strength 0.86
- Edward J Kim · 1 shared grant, 2026 · strength 0.86
- Satveer Jagwani · 1 shared paper, 2025 · strength 0.33
- Amit Singh · 3 shared papers, 2014–2018 · strength 0.27
- Paper In vitro model of inflammatory, hypoxia, and cancer stem cell signaling in pancreatic cancer using heterocellular 3-dim… DOI 10.1101/454397↗
- Paper EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model. DOI 10.1016/j.nano.2015.11.010↗
- Paper Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabi… DOI 10.1186/1471-2407-14-75↗
- George Mattheolabakis · 2 shared papers, 2016–2018 · strength 0.20
- Paper In vitro model of inflammatory, hypoxia, and cancer stem cell signaling in pancreatic cancer using heterocellular 3-dim… DOI 10.1101/454397↗
- Paper EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model. DOI 10.1016/j.nano.2015.11.010↗
- Neha N. Parayath · 1 shared paper, 2021 · strength 0.19
- Gulzar Ahmad · 1 shared paper, 2019 · strength 0.14
- Jing Xu · 2 shared papers, 2012–2014 · strength 0.14
- Paper Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabi… DOI 10.1186/1471-2407-14-75↗
- Paper Therapeutic gene delivery and transfection in human pancreatic cancer cells using epidermal growth factor receptor-targ… DOI 10.3791/3612↗
- Megha Suresh · 1 shared paper, 2018 · strength 0.12
- Mei-Ju Su · 1 shared paper, 2016 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.